Market Overview
The pneumococcal vaccine market was valued at USD 9.16 billion in 2025 and is estimated at USD 9.61 billion in 2026. It is projected to reach USD 14.57 billion by 2034, expanding at a CAGR of 5.30% from 2026 to 2034. Pneumococcal vaccines are immunization products that protect against infections caused by Streptococcus pneumoniae, including pneumonia, meningitis, bacteremia and...
English
Arabic
French
Spanish
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek